The International Society of Nephrology (ISN)

Advancing kidney health worldwide. Together.

The International Society of Nephrology (ISN) is committed to advocacy in order to facilitate the implementation of sustainable, equitable, ethical care for people with kidney disease in all regions and countries of the world.

NCDA full member

About the International Society of Nephrology

We are a philanthropic organisation advancing kidney health worldwide.

Our overarching purpose is to tackle the global burden of acute kidney injury (AKI), chronic kidney disease (CKD) and end-stage kidney disease (ESKD).

We build capacity with healthcare professionals via granting programs, education and research. We bridge gaps in global kidney care, engaging in a collaborative effort with global partners to improve kidney disease prevention, diagnosis and treatment. By connecting communities, we develop a stronger understanding of how to manage kidney disease.

With thousands of professional members from over 150 countries, we represent a wide international network and an efficient platform for timely scientific exchange, debate and communication between healthcare professionals involved in preventing and treating kidney disease. By collaborating with more than 100 national and regional societies, we reach out to tens of thousands health professionals globally.

Advancing kidney health worldwide. Together.

ISN's work on NCDs

850 million people worldwide are now estimated to have some form of kidney disease. The prevalence of chronic kidney diseases worldwide is 10.4% among men and 11.8% among women. Those requiring dialysis or transplantation are between 5.3 and 10.5 million people, although there are many who do not receive these treatments due to lack of resources or financial barriers. Acute kidney injury (AKI), experienced by 13.3 million patients each year.

ISN strives to ensure that kidney disease is recognised as a high priority NCD which now requires urgent consideration by political leaders. We do so by:

  • Getting the evidence: e.g. the Global Kidney Health Atlas, which aims to demonstrate the increasing burden of this disease globally;
  • Making the case: e.g. the development of position papers and advocacy toolkits targeted both at the international and the national level such as our position paper on on the 2018 UN High-Level Meeting on NCDs;
  • Raising awareness: e.g. through our public awareness campaigns such as World Kidney Day, celebrated each year on the second Thursday of March all across the globe, or The Lancet Kidney Campaign, producing compelling arguments on the need to tackle this disease.


Avenue des Arts 1-2
B-1210 Brussels